Searched for
HEPATITIS C DRUG
AbbVie loses patent plea for Hep C drugThe Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...- World Hepatitis Day: Know about causes, symptoms and risk factorsJuly 28 is reserved to promote awareness of this insidious and deadly virus.
- Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in IndiaIndia's Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following pro...
- Johnson & Johnson arm halts R&D on Hepatitis C drugInstead, the company will focus on a cure for chronic hepatitis B, an inflammation of the liver caused by a different virus.
- Patent not to affect hepatitis C drug price in India: Gilead Sciences Inc"It is the company's goal to enable access to these medicines for as many people as possible, as quickly as possible," the spokesperson add...
- Hep C drugs will be a Rs 1,000-cr market; Cimivir-L will boost Biocon's virology biz: Kiran Mazumdar-Shaw"The market for Hepatitis C drugs is fairly large. There are high incidences of Hepatitis C in many parts of our country."
- Strides Shasun gets DCGI nod to manufacture Hepatitis C drugLast year, Strides had entered into a licensing agreement with Gilead Sciences to bring Hepatitis C cure to 91 developing countries.
- New medicine for Hepatitis C treatment launchedDuring the conference, two new drugs were launched for treatment of Hepatitis C disease at affordable price.
- Hetero receives drug controller approval for generic DaclatasvirDaclatasvir in combination with Sofosbuvir is indicated for the treatment of Hepatitis C genotype 3 infections, which is highly prevalent i...
- Hetero gets DCGI approval to market Hepatitis C drugHetero is the first company in India to receive the approval for the fixed-dose combination Ledipasvir-Sofosbuvir (90mg/400mg) from DCGI.
- Roche cuts Hepatitis C drug cost by 65% for government institutionsDrug major Roche has reduced the prices of its Hepatitis C treatment drug 'Exxura' by 65 per cent across all government institutions in Ind...
- Strides Arcolab launches generic version of SofosbuvirStrides Arcolab today announced launch of the generic version of Hepatitis C drug 'Sofosbuvir' under the brand name 'Virso'.
- Cipla to launch generic Hepatitis C drug 'Hepcvir' in IndiaThe availability of product in other markets is subject to approvals from the regulatory authorities in respective countries, Cipla said.
- Dr Reddy's shares up on Hepatitis C drug launch planShares of Dr Reddy's Laboratories today settled with gains of nearly 2 per cent after the firm said it is planning to launch Hepatitis C dr...
- Dr Reddy's to launch Hepatitis C drug in IndiaSofosbuvir is a medicine used for chronic Hepatitis C infection and sold globally by Gilead Sciences Inc, under its brand Sovaldi.
- Zydus Cadila launches Gilead's Hepatitis C drug in IndiaSofosbuvir is a medicine used for chronic hepatitis C infection and sold globally by Gilead Sciences Inc, under its brand Sovaldi.
- Natco Pharma ties up with Gilead Sciences for Hepatitis C drugNatco was the only Indian generic drug maker that had filed a pre-grant patent opposition for the drug with the patent office.
- Gilead's hepatitis C drug licensing to benefit more patients: SitharamanA delegation of Gilead Sciences Inc yesterday met Commerce and Industry Minister Nirmala Sitharaman and informed about the signing of non-e...
- 96,000 die every year due to Hepatitis C in India: ReportThe report said the prevalence of Hepatitis C is estimated to be within 1.8-2.5 per cent, while among drug users it is 50-90 per cent.
- IPAB's verdict on Roche's Hepatitis C drug patent may impact MerckThe IPAB revoked Roche's patent for Pegasys on grounds that the process of pegylation did not enhance the efficacy of the drug.
Load More
